期刊
ACS CHEMICAL BIOLOGY
卷 14, 期 9, 页码 1904-1912出版社
AMER CHEMICAL SOC
DOI: 10.1021/acschembio.9b00367
关键词
-
资金
- Wellcome Trust Investigator Award [104641/Z/14/Z]
- Boehringer-Ingelheim Fonds PhD Fellowship
- Janggen-Pohn-Stiftung Award
- Swiss National Science Foundation Award
- Wellcome Trust [104641/Z/14/Z] Funding Source: Wellcome Trust
Nucleoside analogues are widely used in clinical practice as chemotherapy drugs. Arabinose nucleoside derivatives such as fludarabine are effective in the treatment of patients with acute and chronic leukemias and non-Hodgkin's lymphomas. Although nucleoside analogues are generally known to function by inhibiting DNA synthesis in rapidly proliferating cells, the identity of their in vivo targets and mechanism of action are often not known in molecular detail. Here we provide a structural basis for arabinose nucleotide-mediated inhibition of human primase, the DNA-dependent RNA polymerase responsible for initiation of DNA synthesis in DNA replication. Our data suggest ways in which the chemical structure of fludarabine could be modified to improve its specificity and affinity toward primase, possibly leading to less toxic and more effective therapeutic agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据